13th Aug 2021 15:12
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | J.P. Morgan Securities LLC |
Company dealt in | Xeris Pharmaceuticals, Inc. |
Class of relevant security to which the dealings being disclosed relate (Note 2) | $0.001 common stock |
Date of dealing | 12 August 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities | 2,766,004 4.16 | 136,092 0.20 | ||||
(2) Derivatives (other than options) | 124,443 0.19 |
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total | 2,890,447 4.35 | 136,092 0.20 | ||||
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale |
Number of relevant securities |
Price per unit (USD)
(Note 5) |
Sale(Borrow Return)
Purchases Purchases Purchases
Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales | 698,300
1 539 4,046
200 3,600 1,000 6,600 1,168 252 3,701 170 800 200 12,099 1,500 5,402 530 3,800 5,202 400 4,350 5,063 8,070 4,100 500 1,800 2,558 8,300 4,500 2,427 400 900 1,280 12,099 600 798 303 700 900 100 500 500 300 44,122 1,090 800 4,900 11,004 14,546 50,221 2,900 6,810 1,301 79,797 5,275 700 | N/A
2.4250 USD 2.4300 USD 2.5499 USD
2.3600 USD 2.3700 USD 2.3720 USD 2.3800 USD 2.3840 USD 2.3843 USD 2.3900 USD 2.3906 USD 2.3938 USD 2.3950 USD 2.4000 USD 2.4013 USD 2.4020 USD 2.4025 USD 2.4028 USD 2.4045 USD 2.4050 USD 2.4057 USD 2.4076 USD 2.4100 USD 2.4105 USD 2.4120 USD 2.4144 USD 2.4162 USD 2.4200 USD 2.4220 USD 2.4232 USD 2.4250 USD 2.4278 USD 2.4300 USD 2.4347 USD 2.4350 USD 2.4374 USD 2.4396 USD 2.4400 USD 2.4500 USD 2.4550 USD 2.4600 USD 2.4660 USD 2.5774 USD 2.6013 USD 2.6202 USD 2.6250 USD 2.6300 USD 2.6400 USD 2.6465 USD 2.6469 USD 2.6483 USD 2.6500 USD 2.6546 USD 2.6583 USD 2.6600 USD 2.6800 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (USD) (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and
any other person relating to the voting rights of any relevant securities under any option referred to
on this form or relating to the voting rights or future acquisition or disposal of any relevant securities
to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure | 13 August 2021 |
Contact name | Alwyn Basch |
Telephone number | 0207 742 7407 |
If a connected EFM, name of offeree/offeror with which connected | N/A |
If a connected EFM, state nature of connection (Note 10) | N/A |
Related Shares:
Xeris Biopharma